Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IMRX - Immuneering Corp - Ordinary Shares Class A


IEX Last Trade
1.11
-0.050   -4.505%

Share volume: 264,507
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$1.16
-0.05
-4.31%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
12%
Profitability 0%
Dept financing 2%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
3.74%
1 Month
-1.77%
3 Months
-19.57%
6 Months
-82.52%
1 Year
-87.87%
2 Year
-80.11%
Key data
Stock price
$1.11
P/E Ratio 
-0.64
DAY RANGE
N/A - N/A
EPS 
-$1.86
52 WEEK RANGE
$1.00 - $9.14
52 WEEK CHANGE
-$0.88
MARKET CAP 
32.915 M
YIELD 
N/A
SHARES OUTSTANDING 
29.653 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
2.11
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$265,750
AVERAGE 30 VOLUME 
$687,138
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news